Celgene (CELG) Tops Q4 EPS by 3c, FY Guidance Tops Views

Celgene (NASDAQ: CELG) reported Q4 EPS of $2.00, $0.03 better than the analyst estimate of $1.97. Revenue for the quarter came in at $3.48 billion versus the consensus estimate of $3.47 billion.

GUIDANCE:

Celgene sees FY2018 EPS of $8.70-$8.90, versus the consensus of $8.64. Celgene sees FY2018 revenue of $14.4-14.8 billion, versus the consensus of $14.82 billion.

For earnings history and earnings-related data on Celgene (CELG) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49